{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T09:31:31Z","timestamp":1791538291172,"version":"4.3.4"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,8]]},"DOI":"10.1093\/jac\/44.2.263","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:24:55Z","timestamp":1027722295000},"page":"263-273","source":"Crossref","is-referenced-by-count":149,"title":["Treatment of hospitalized patients with complicated Gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin\/dalfopristin versus cefazolin, oxacillin or vancomycin"],"prefix":"10.1093","volume":"44","author":[{"given":"Ronald L.","family":"Nichols","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald R.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Barriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel E.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Zervos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Kreter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[1999,8]]},"reference":[{"key":"key\n\t\t\t\t20170411034413_R1","unstructured":"Swartz, M. N. (1995). Cellulitis and subcutaneous tissue infections. In Principles and Practice of Infectious Diseases, 4th edn, (Mandell, G. L., Bennett, J. E.& Dolin, R., Eds), pp. 909\u201328. Churchill Livingstone, New York."},{"key":"key\n\t\t\t\t20170411034413_R2","unstructured":"Swartz, M. N. (1995). Myositis. In Principles and Practice of Infectious Diseases, 4th edn, (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 929\u201335. Churchill Livingstone, New York."},{"key":"key\n\t\t\t\t20170411034413_R3","unstructured":"Centers for Disease Control. (1997). Reduced susceptibility of Staphylococcus aureus to vancomycin\u2014Japan, 1996. Morbidity and Mortality Weekly Report46, 624\u20136."},{"key":"key\n\t\t\t\t20170411034413_R4","unstructured":"Centers for Disease Control. (1997). Staphylococcus aureus with reduced susceptibility to vancomycin\u2014United States. Morbidity and Mortality Weekly Report46, 765\u20136."},{"key":"key\n\t\t\t\t20170411034413_R5","doi-asserted-by":"crossref","unstructured":"Brumfitt, W., Hamilton-Hiller, J. M. J. & Shah, S. (1992). In-vitro activity of RP59500, a new semisynthetic streptogramin antibiotic, against Gram-positive bacteria. Journal of Antimicrobial Chemotherapy 30, Suppl. A,29\u201337.","DOI":"10.1093\/jac\/30.suppl_A.29"},{"key":"key\n\t\t\t\t20170411034413_R6","doi-asserted-by":"crossref","unstructured":"Leclercq, R., Nantas, L., Soussy, C. J. & Duval, J. (1992). Activity of RP59500 a new parenteral semisynthetic streptogramin against staphylococci with various mechanisms of resistance to macrolide lincosamide streptogramin antibiotics. Journal of Antimicrobial Chemotherapy30, Suppl. A,67\u201375.","DOI":"10.1093\/jac\/30.suppl_A.67"},{"key":"key\n\t\t\t\t20170411034413_R7","doi-asserted-by":"crossref","unstructured":"Appelbaum, L. C., Spangler, S. K. & Jacobs, M. R. (1993). Susceptibility of 539 Gram-positive and Gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin, and piperacillin\/tazobactam. Journal of Antimicrobial Chemotherapy32, 223\u201331.","DOI":"10.1093\/jac\/32.2.223"},{"key":"key\n\t\t\t\t20170411034413_R8","doi-asserted-by":"crossref","unstructured":"Nadler, H., Dowzicky, M. J., Feger, C., Pease, M. R. & Prokocimer, P. (1999). Synercid (quinupristin\/dalfopristin): a novel selective-spectrum antibiotic for the treatment of multi-drug resistant and other Gram-positive pathogens. Clinical Microbiology Newsletter (In press).","DOI":"10.1016\/S0196-4399(00)80041-0"},{"key":"key\n\t\t\t\t20170411034413_R9","doi-asserted-by":"crossref","unstructured":"Calandra, G. B., Norden, C., Nelson, J. D. & Mader, J. T. (1992). Evaluation of new anti-infective drugs in the treatment of selected infections of the skin and skin structure. Clinical Infectious Diseases15, Suppl. 1,S148\u201354.","DOI":"10.1093\/clind\/15.Supplement_1.S148"},{"key":"key\n\t\t\t\t20170411034413_R10","doi-asserted-by":"crossref","unstructured":"Zelen, M. (1974). The randomization and stratification of patients to clinical trials. Journal of Chronic Diseases27, 365\u201375.","DOI":"10.1016\/0021-9681(74)90015-0"},{"key":"key\n\t\t\t\t20170411034413_R11","doi-asserted-by":"crossref","unstructured":"Maki, D., Weise, C. & Sarafin, H. (1977). A semiquantitative culture method for identifying intravenous catheter-related infections. New England Journal of Medicine 296, 1305\u20139.","DOI":"10.1056\/NEJM197706092962301"},{"key":"key\n\t\t\t\t20170411034413_R12","unstructured":"National Committee for Clinical Laboratory Standards. (1990). Performance Standards for Antimicrobial Disk Susceptibility Tests\u2014Fourth Edition: Document M2-A4. NCCLS, Villanova, PA."},{"key":"key\n\t\t\t\t20170411034413_R13","unstructured":"National Committee for Clinical Laboratory Standards. (1990). Methods for Dilution Antimicrobial Susceptibility Tests for Organisms that Grow Aerobically\u2014Second Edition: Approved Standard M7-A2. NCCLS, Villanova, PA."},{"key":"key\n\t\t\t\t20170411034413_R14","doi-asserted-by":"crossref","unstructured":"Tan, J. S., Wishnow, R. M., Talan, D. A., Duncanson, F. P. & Norden, C. W. (1993). Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. Antimicrobial Agents and Chemotherapy37, 1580\u20136.","DOI":"10.1128\/AAC.37.8.1580"},{"key":"key\n\t\t\t\t20170411034413_R15","unstructured":"Rehm, S. J., Schmitt, S. K., Gordon S. M., Adal, K. A., Mawhorter, S. D., Brakeman, J. et al. (1998). Experience with quinupristin\/ dalfopristin (RP59500 Synercid), administration outside the hospital. In Program and Abstracts of the Eighth International Congress of Infectious Diseases, Boston, USA, 1998. Abstract 48.022. International Society of Infectious Diseases."}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/44\/2\/263\/13057098\/JAC442263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T08:24:00Z","timestamp":1583310240000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/44.2.263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[1999,8]]},"published-print":{"date-parts":[[1999,8]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/44.2.263","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[1999,8]]}}}